187 related articles for article (PubMed ID: 25001195)
1. In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.
Newton-Northup JR; Dickerson MT; Kumar SR; Smith GP; Quinn TP; Deutscher SL
Mol Imaging Biol; 2014 Dec; 16(6):854-64. PubMed ID: 25001195
[TBL] [Abstract][Full Text] [Related]
2. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.
Larimer BM; Thomas WD; Smith GP; Deutscher SL
Mol Imaging Biol; 2014 Aug; 16(4):449-58. PubMed ID: 24550054
[TBL] [Abstract][Full Text] [Related]
3. Characterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.
Newton-Northup J; Deutscher SL
Methods Mol Biol; 2017; 1572():445-465. PubMed ID: 28299705
[TBL] [Abstract][Full Text] [Related]
4. Streamlined in vivo selection and screening of human prostate carcinoma avid phage particles for development of peptide based in vivo tumor imaging agents.
Newton-Northup JR; Figueroa SD; Deutscher SL
Comb Chem High Throughput Screen; 2011 Jan; 14(1):9-21. PubMed ID: 20958260
[TBL] [Abstract][Full Text] [Related]
5. Improving Pharmacokinetics of Peptides Using Phage Display.
Asar M; Newton-Northup J; Soendergaard M
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675913
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
[TBL] [Abstract][Full Text] [Related]
7. Influence of chelate conjugation on a newly identified tumor-targeting peptide.
Mier W; Zitzmann S; Krämer S; Reed J; Knapp EM; Altmann A; Eisenhut M; Haberkorn U
J Nucl Med; 2007 Sep; 48(9):1545-52. PubMed ID: 17704241
[TBL] [Abstract][Full Text] [Related]
8. Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors.
Kennel SJ; Mirzadeh S; Hurst GB; Foote LJ; Lankford TK; Glowienka KA; Chappell LL; Kelso JR; Davern SM; Safavy A; Brechbiel MW
Nucl Med Biol; 2000 Nov; 27(8):815-25. PubMed ID: 11150716
[TBL] [Abstract][Full Text] [Related]
9. In vitro high throughput phage display selection of ovarian cancer avid phage clones for near-infrared optical imaging.
Soendergaard M; Newton-Northup JR; Deutscher SL
Comb Chem High Throughput Screen; 2014; 17(10):859-67. PubMed ID: 25360673
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional phage-based pretargeted imaging of human prostate carcinoma.
Newton-Northup JR; Figueroa SD; Quinn TP; Deutscher SL
Nucl Med Biol; 2009 Oct; 36(7):789-800. PubMed ID: 19720291
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.
Kumar SR; Quinn TP; Deutscher SL
Clin Cancer Res; 2007 Oct; 13(20):6070-9. PubMed ID: 17947470
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
[TBL] [Abstract][Full Text] [Related]
13. Identification of chondrocyte-binding peptides by phage display.
Cheung CS; Lui JC; Baron J
J Orthop Res; 2013 Jul; 31(7):1053-8. PubMed ID: 23440926
[TBL] [Abstract][Full Text] [Related]
14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
15. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.
Cheng Z; Chen J; Miao Y; Owen NK; Quinn TP; Jurisson SS
J Med Chem; 2002 Jul; 45(14):3048-56. PubMed ID: 12086490
[TBL] [Abstract][Full Text] [Related]
16. Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
Loi M; Di Paolo D; Soster M; Brignole C; Bartolini A; Emionite L; Sun J; Becherini P; Curnis F; Petretto A; Sani M; Gori A; Milanese M; Gambini C; Longhi R; Cilli M; Allen TM; Bussolino F; Arap W; Pasqualini R; Corti A; Ponzoni M; Marchiò S; Pastorino F
J Control Release; 2013 Sep; 170(2):233-41. PubMed ID: 23714122
[TBL] [Abstract][Full Text] [Related]
17. Use of a Phage-Display Method to Identify Peptides that Bind to a Tin Oxide Nanosheets.
Nakazawa H; Seta Y; Hirose T; Masuda Y; Umetsu M
Protein Pept Lett; 2018; 25(1):68-75. PubMed ID: 29210630
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
19. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
Kumar SR; Deutscher SL
J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune responses against gonadotropin releasing hormone elicited by immunization with phage-peptide constructs obtained via phage display.
Samoylov A; Cochran A; Schemera B; Kutzler M; Donovan C; Petrenko V; Bartol F; Samoylova T
J Biotechnol; 2015 Dec; 216():20-8. PubMed ID: 26456116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
